PreveCeutical closes $215,000 private placement tranche at $0.025 per unit

• PreveCeutical Medical closed a fourth tranche of a non-brokered private placement, issuing 8,600,000 units at $0.025 for gross proceeds of $215,000.
• Aggregate gross proceeds across four tranches total $1 million.
• Each unit includes one common share, plus one-half warrant exercisable at $0.05 for two years.
• Warrant expiry can be accelerated if shares close at or above $0.08 for 10 consecutive sessions; prior releases misstated the trigger at $0.10.
• Paid a $17,200 cash finder’s fee; issued 688,000 finder’s warrants at $0.05 for two years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Preveceutical Medical Inc. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.